News
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration announced ...
The U.S. Food and Drug Administration on Monday named Sean Keveney as its new chief counsel, placing him in charge of ...
The FDA 's classification of the Queen Bee Gardens recall as Class II signals a moderate health risk, indicating that use or ...
The supplemental New Drug Application is supported by data from the Phase II TRANSCEND FL trial (NCT04245839), which showed ...
19h
MedPage Today on MSNDid FDA Pick the Wrong COVID Vaccine Strain Last Season?The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
The first wave of public comments on the FDA/USDA request for information on defining ‘ultra-processed foods’ is ...
After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit ...
The FDA has approved VIZZ eye drops (LENZ Therapeutics, Inc.) for the treatment of presbyopia, the gradual loss of near ...
US Food and Drug Administration Commissioner Marty Makary said he’s trying to persuade Vinay Prasad, the agency’s former head ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results